The modality of dialysis treatment: Does it influence the response to erythropoietin treatment?

Nephrology Dialysis Transplantation

Volumn 16, Issue 10, 2001, Pages 1971-1974

  Locatelli, Francesco ^a   Del Vecchio, Lucia ^a   Andrulli, Simeone ^a  

^a A MANZONI HOSPITAL   (Italy)

Author keywords

Anaemia; Convective treatments; Dialysis dose; Haemodialysis; Membrane; On line treatments

Indexed keywords

CUPROPHANE; DIALYSIS FLUID; HEMOGLOBIN; POLY(METHYL METHACRYLATE); POLYSULFONE; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BIOCOMPATIBILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DOSE RESPONSE; DRUG RESPONSE; EDITORIAL; ERYTHROPOIESIS; HEMATOCRIT; HEMODIALYSIS PATIENT; HEMOLYSIS; HUMAN; KIDNEY FAILURE; MEMBRANE PERMEABILITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034790098     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.10.1971     Document Type: Editorial

References (21)

1. The impact of hematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - The experience of the Lombardy Dialysis Registry
2. Hematocrit level and associated mortality in hemodialysis patients
3. Predictors of target hematocrit among erythropoietin-treated HD patients
4. Hematocrit and erythropoietin dose are associated with dose of dialysis among adult hemodialysis patients: Results from the 1998 ESRD Core Indicators Project
5. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease
6. Adequacy of dialysis and differences in hematocrit among dialysis facilities
7. Adequacy of dialysis reduces the doses of recombinant erythropoietin independently form the use of biocompatibles membranes in hemodialysis patients
8. Anaemia and blood pressure correction obtained by daily hemodialysis induce a reduction of left ventricular hypertrophy in dialysed patients
9. Clinical and biochemical correlates of starting "daily" hemodialysis
10. Fluid state and blood pressure control in patients treated with long and short haemodialysis
11. Removal of high molecular weight substances with large pore size membrane (BK-F)
12. La polisulfona de alta permeabilidad mejora la respuesta de la anemia a la eritropoyetina en hemodialisis
13. Effect on alleviation of renal anemia by hemodialysis using the high-flux dialyzer (BK-F)
14. Effect of high-flux dialysis on the anemia of haemodialysis patients
15. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters
16. Change from conventional haemodiafiltration to on-line haemodiafiltration
17. Haemodiafiltration with substitution of fluid prepared on-line decreases rHuEPO consumption
18. A comparison of on-line hemodiafiltration and high flux hemodialysis: A prospective clinical study
19. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study
20. Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients
21. Multistate outbreak of hemolysis in hemodialysis patients traced to faulty blood tubing sets